Get the tools used by (smart)² investors.

Watchlists Ideas Screener Data Explorer Charts Saved Work

Net Debt / Total Capital for Novartis AG

Join now and get access to the full platform

Search for company or ETF

0 results available. Select is focused ,type to refine list, press Down to open the menu,

0QLR: Novartis AG

Novartis AG engages in the research, development, manufacture, distribution, marketing, and sale of pharmaceutical medicines in Switzerland and internationally. The company offers Entresto, an angiote...

97.67 CHF

Price

– CHF

Fair Value

–

Upside

83.61 - 115.98

52-week range

Create Chart Create Model Add To Watchlist

Analysis

Fiscal Years

Trailing Twelve Months

Fiscal Halfs

Fiscal Quarters

Daily

Hide this widget

The following section summarizes insights on Novartis AG's Net Debt / Total Capital:

Performance Summary

Novartis's latest twelve months net debt / total capital is 7.5%
Novartis's net debt / total capital for fiscal years ending December 2020 to 2024 averaged 7.9%.
Novartis's operated at median net debt / total capital of 7.5% from fiscal years ending December 2020 to 2024.
Looking back at the last 5 years, Novartis's net debt / total capital peaked in December 2021 at 11.3%.
Novartis's net debt / total capital hit its 5-year low in December 2022 of 4.3%.
Novartis's net debt / total capital decreased in 2022 (4.3%, -62.3%) and increased in 2020 (10.9%, +23.9%), 2021 (11.3%, +4.4%), 2023 (5.3%, +24.5%), and 2024 (7.5%, +41.8%).

How does Novartis's Net Debt / Total Capital benchmark against competitors?

Hide this widget

We've identified the following companies as similar to Novartis AG because they operate in a related industry or sector. We also considered size, growth, and various financial metrics to narrow down the list to the ones listed below.

Novartis Net Debt / Total Capital Benchmarks
Name	Ticker	Net Debt / Total Capital
Johnson & Johnson	BRSE:000943981	-
Bristol-Myers Squibb Co	BRSE:BMY	-
Bayer AG	SWX:BAYN	-
Eli Lilly and Co	SWX:LLY	4.1%
Healthcare	SECTOR:HLTH.CH	4.9%
Roche Holding AG	SWX:RO	7.0%
Novartis AG	LSE:0QLR	7.5%
Merck & Co., Inc.	BRSE:010683053	9.6%
Sandoz Group AG	SWX:SDZ	16.3%
Pfizer Inc	DB:PFE	22.7%
Teva Pharmaceutical Industries Limited	SWX:TEVA	41.3%
Viatris Inc	WBAG:VTRS	53.8%

Metric Usage: Net Debt / Total Capital

Hide this widget

net_debt_to_capital

Slug

number

Datatype

text

Format

current

Default Period

FY, LTM

Periods Supported

Free

Plan

To view the full list of supported financial metrics please see Complete Metrics Listing.

Similar Metrics

Hide this widget

Metrics similar to Net Debt / Total Capital in the risk category include:

Sloan Ratio - A formula developed by Richard Sloan in 1996 that measures the degree of accruals versus reported earnings.
Cash / Total Capital - A ratio that measures the level of the cash relative to the market value of total capital.
Beta (5 Year) - A ratio that measures the risk or volatility of a company's share price in comparison to the market as a whole. A beta of 1.0 means that the company rises and falls in direct relationship to the movement of the benchmark index. A beta that is less than 1 indicates a stock that is less volatile than the overall market and a beta greater than 1 indicates that the stock is more volatile.
Cash Flow to Current Liabilities - A ratio that measures the amount of operating cash flow a firm generates on each dollar of current liabilities.

View Full List

Search for metric or datapoint

Net Debt / Total Capital

A ratio that measures the level of the net debt relative to the market value of total capital. Net debt is the sum of all long term debt fields minus ...

Definition of Net Debt / Total Capital

Hide this widget

A ratio that measures the level of the net debt relative to the market value of total capital. Net debt is the sum of all long term debt fields minus cash and short-term investments.

Sector Benchmark Analysis

Sector

Industry Group

Industry

Hide this widget

The chart above depicts the distribution of net debt / total capital for companies operating in the Healthcare sector in the Developed economic region. Over 2,450 companies were considered in this analysis, and 2,355 had meaningful values. The average net debt / total capital of companies in the sector is -13.2% with a standard deviation of 53.0%.

Novartis AG's Net Debt / Total Capital of 7.5% ranks in the 69.0% percentile for the sector. The following table provides additional summary stats:

Net Debt / Total Capital In The Healthcare Sector
Economic Risk Region	Developed
Total Constituents	2,453
Included Constituents	2,355
Min	-234.1%
Max	89.2%
Median	-3.6%
Mean	-13.2%
Standard Deviation	53.0%

You can find companies with similar net debt / total capital using this stock screener.